The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

Value Health. 2014 Nov;17(7):A343. doi: 10.1016/j.jval.2014.08.689. Epub 2014 Oct 26.
No abstract available